Skip to content

Profound Medical PROF DE — Revenue

Other geography segments

CA
$3.57M+319%
US
$1.62M+4.7%

Similar metrics at other companies

Ondas, Inc.
 logo
ONDSDE — Revenue
$1.65M
Oracle logo
ORCLDE — Revenue
$498.25M+9.7%
Arrow Electronics logo
ARWDE — Revenue
$1.02B+42.2%
Vishay Intertechnology logo
VSHDE — Revenue
$226.04M+3.8%
Euronet Worldwide logo
EEFTDE — Revenue
$189.08M+7.1%
LeMaitre Vascular logo
LMATDE — Revenue (Gross)
$5.54M+39.3%

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K
Free cash flow-$9.6M

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's de — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's DE — revenue?
Profound Medical (PROF) reported DE — revenue of $150K in Q1 2026.
How has Profound Medical's DE — revenue changed year-over-year?
Profound Medical's DE — revenue decreased by 33.6% year-over-year, from $226K to $150K.
What is the long-term trend for Profound Medical's DE — revenue?
Over 2 years (2023 to 2025), Profound Medical's DE — revenue has grown at a -35.2% compound annual growth rate (CAGR), from $1.84M to $773K.
What does DE — revenue mean?
This metric represents the total gross revenue generated by the company within the specific geographic segment identified as DE. It reflects the market adoption and commercial success of the company's therapeutic systems in this region. Tracking this figure helps investors evaluate regional growth trends and the effectiveness of local sales strategies.